Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 4,451–4,500 of 4,598 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05648487	HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasis	not yet recruiting	Phase 2	46	Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityOTHER	0	Dec 16, 2022	clinicaltrials
NCT05644743	Clinical Transformation of Organoid Model to Predict the Efficacy of GC in the Treatment of Intrahepatic Cholangiocarcinoma	not yet recruiting	—	40	Chengjun Sui,MDOTHER	0	Dec 9, 2022